Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells in vitro
BackgroundOxyberberine (OBB) is a naturally occurring isoquinoline alkaloid that is believed to possess various health-promoting properties, including anti-fungus, hepatoprotection, anti-inflammation, and anti-intestinal mucositis effects. Despite several studies reporting the health benefits of OBB...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1496874/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841556628570112000 |
|---|---|
| author | Cailan Li Cailan Li Cailan Li Jiahao Wang Hongmei Yang Shuang Luo Qiang Lu |
| author_facet | Cailan Li Cailan Li Cailan Li Jiahao Wang Hongmei Yang Shuang Luo Qiang Lu |
| author_sort | Cailan Li |
| collection | DOAJ |
| description | BackgroundOxyberberine (OBB) is a naturally occurring isoquinoline alkaloid that is believed to possess various health-promoting properties, including anti-fungus, hepatoprotection, anti-inflammation, and anti-intestinal mucositis effects. Despite several studies reporting the health benefits of OBB in treating ulcerative colitis (UC), its specific mechanism of action has yet to be fully elucidated.PurposeThis investigation is designed to explore the potential protective efficacy of OBB and the latent mechanism using an in vitro model of UC-like inflammatory intestinal cells.MethodsCaco-2 cells were pretreated with OBB and subsequently exposed to lipopolysaccharide (LPS). The transepithelial electrical resistance (TEER), paracellular permeability, and the distribution and expression of tight- and adherent junction proteins were determined to assess barrier integrity. The levels of proinflammatory cytokines, reactive oxygen species (ROS), Nrf2, and NF-κB signaling cascade were analyzed via ELISA, qRT-PCR, immunofluorescence, or Western blotting.ResultsOBB was found to mitigate the effects of LPS on Caco-2 cell monolayers, as evidenced by the improvement in TEER and the decrease in FITC-dextran flux. Moreover, OBB ameliorated the LPS-induced decrease in the distribution and expression of several tight junction markers, including ZO-1, occludin, and E-cadherin. In addition, OBB treatment effectively inhibited LPS-induced increases in ROS, apoptosis, and Keap1 and decreases in Nrf2 and HO-1. LPS-induced elevations in nuclear NF-κB p65 and p-IκBα were suppressed by OBB. In addition, ML385, an antagonist of Nrf2, abolished the protective role of OBB.ConclusionOBB has a pronounced beneficial effect on LPS-induced damage to enteral barrier function, and the regulation of the Nrf2/NF-κB pathway is an important mechanism responsible for the protection afforded by OBB. |
| format | Article |
| id | doaj-art-2ed3dfcd6713459f8ca070e88ec024ff |
| institution | Kabale University |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-2ed3dfcd6713459f8ca070e88ec024ff2025-01-07T06:45:59ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011510.3389/fphar.2024.14968741496874Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells in vitroCailan Li0Cailan Li1Cailan Li2Jiahao Wang3Hongmei Yang4Shuang Luo5Qiang Lu6Department of Pharmacology, Zunyi Medical University, Zhuhai, ChinaKey Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, ChinaKey Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi, ChinaDepartment of Pharmacology, Zunyi Medical University, Zhuhai, ChinaFaculty of Health Sciences, University of Macau, Taipa, Macao SAR, ChinaShenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, ChinaDepartment of Pharmaceutical Sciences, Zunyi Medical University, Zhuhai, ChinaBackgroundOxyberberine (OBB) is a naturally occurring isoquinoline alkaloid that is believed to possess various health-promoting properties, including anti-fungus, hepatoprotection, anti-inflammation, and anti-intestinal mucositis effects. Despite several studies reporting the health benefits of OBB in treating ulcerative colitis (UC), its specific mechanism of action has yet to be fully elucidated.PurposeThis investigation is designed to explore the potential protective efficacy of OBB and the latent mechanism using an in vitro model of UC-like inflammatory intestinal cells.MethodsCaco-2 cells were pretreated with OBB and subsequently exposed to lipopolysaccharide (LPS). The transepithelial electrical resistance (TEER), paracellular permeability, and the distribution and expression of tight- and adherent junction proteins were determined to assess barrier integrity. The levels of proinflammatory cytokines, reactive oxygen species (ROS), Nrf2, and NF-κB signaling cascade were analyzed via ELISA, qRT-PCR, immunofluorescence, or Western blotting.ResultsOBB was found to mitigate the effects of LPS on Caco-2 cell monolayers, as evidenced by the improvement in TEER and the decrease in FITC-dextran flux. Moreover, OBB ameliorated the LPS-induced decrease in the distribution and expression of several tight junction markers, including ZO-1, occludin, and E-cadherin. In addition, OBB treatment effectively inhibited LPS-induced increases in ROS, apoptosis, and Keap1 and decreases in Nrf2 and HO-1. LPS-induced elevations in nuclear NF-κB p65 and p-IκBα were suppressed by OBB. In addition, ML385, an antagonist of Nrf2, abolished the protective role of OBB.ConclusionOBB has a pronounced beneficial effect on LPS-induced damage to enteral barrier function, and the regulation of the Nrf2/NF-κB pathway is an important mechanism responsible for the protection afforded by OBB.https://www.frontiersin.org/articles/10.3389/fphar.2024.1496874/fullulcerative colitisoxyberberineintestinal barrierinflammationNrf2NF-κB |
| spellingShingle | Cailan Li Cailan Li Cailan Li Jiahao Wang Hongmei Yang Shuang Luo Qiang Lu Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells in vitro Frontiers in Pharmacology ulcerative colitis oxyberberine intestinal barrier inflammation Nrf2 NF-κB |
| title | Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells in vitro |
| title_full | Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells in vitro |
| title_fullStr | Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells in vitro |
| title_full_unstemmed | Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells in vitro |
| title_short | Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells in vitro |
| title_sort | oxyberberine alleviates lipopolysaccharide induced intestinal barrier disruption and inflammation in human colonic caco 2 cells in vitro |
| topic | ulcerative colitis oxyberberine intestinal barrier inflammation Nrf2 NF-κB |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2024.1496874/full |
| work_keys_str_mv | AT cailanli oxyberberinealleviateslipopolysaccharideinducedintestinalbarrierdisruptionandinflammationinhumancoloniccaco2cellsinvitro AT cailanli oxyberberinealleviateslipopolysaccharideinducedintestinalbarrierdisruptionandinflammationinhumancoloniccaco2cellsinvitro AT cailanli oxyberberinealleviateslipopolysaccharideinducedintestinalbarrierdisruptionandinflammationinhumancoloniccaco2cellsinvitro AT jiahaowang oxyberberinealleviateslipopolysaccharideinducedintestinalbarrierdisruptionandinflammationinhumancoloniccaco2cellsinvitro AT hongmeiyang oxyberberinealleviateslipopolysaccharideinducedintestinalbarrierdisruptionandinflammationinhumancoloniccaco2cellsinvitro AT shuangluo oxyberberinealleviateslipopolysaccharideinducedintestinalbarrierdisruptionandinflammationinhumancoloniccaco2cellsinvitro AT qianglu oxyberberinealleviateslipopolysaccharideinducedintestinalbarrierdisruptionandinflammationinhumancoloniccaco2cellsinvitro |